Detalhe da pesquisa
1.
Inhibition of Galectins and the P2X7 Purinergic Receptor as a Therapeutic Approach in the Neurovascular Inflammation of Diabetic Retinopathy.
Int J Mol Sci
; 24(11)2023 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37298672
2.
Galectin 1-A Key Player between Tissue Repair and Fibrosis.
Int J Mol Sci
; 23(10)2022 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35628357
3.
Systemic Beta-Hydroxybutyrate Affects BDNF and Autophagy into the Retina of Diabetic Mice.
Int J Mol Sci
; 23(17)2022 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077579
4.
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes.
Front Pharmacol
; 15: 1402782, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38835659
5.
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials.
Cells
; 12(14)2023 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37508552
6.
Serum Iba-1, GLUT5, and TSPO in Patients With Diabetic Retinopathy: New Biomarkers for Early Retinal Neurovascular Alterations? A Pilot Study.
Transl Vis Sci Technol
; 11(3): 16, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35285861
7.
The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome.
PLoS One
; 14(1): e0211005, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30657794
8.
Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach.
Br J Pharmacol
; 176(13): 2179-2194, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30883703